454 Life Sciences Initiates Collaborative Research Agreement with the Broad Institute
Collaboration Aims to Facilitate Disease-Related Genomic Studies
454 Life Sciences Corporation announced the initiation of a collaborative research agreement with the Broad Institute of MIT and Harvard, a research collaboration of the Massachusetts Institute of Technology, Harvard University and its hospitals and the Whitehead Institute for Biomedical Research. Under the collaboration, researchers at the Broad Institute will use 454 Life Sciences' system to conduct disease-related genomic studies in order to study the genetic basis for complex diseases, such as cancer, diabetes and heart disease. 454 Life Sciences has enabled its Genome Sequencer 20 System to perform "Ultra-deep Sequencing"(TM) of specific genes of interest for use in the collaboration.
Most read news
Topics
Organizations
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.